Related Experiment Video
Updated: Nov 9, 2025

08:57
Layered Alginate Constructs: A Platform for Co-culture of Heterogeneous Cell Populations
Published on: August 7, 2016
8.1K
Engineered cell-laden alginate microparticles for 3D culture
Bumseok Namgung1,2, Kalpana Ravi1,2, Pooja Prathyushaa Vikraman1,2
1Center for Engineered Therapeutics, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, U.S.A.
Biochemical Society Transactions
|April 16, 2021
Summary
Advanced microfabrication enables creating 3D tissue models using alginate hydrogel microparticles. These engineered microparticles offer a high-throughput platform for drug screening and cell-based therapies.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Microfabrication
Background:
- Advanced microfabrication and biocompatible hydrogels are crucial for modeling 3D tissue microenvironments.
- Hydrogel microparticles provide a high-throughput platform for studying cell-microenvironment interactions.
- Alginate is a preferred hydrogel material due to its cytocompatibility, gelation properties, and biocompatibility.
Purpose of the Study:
- To review engineering approaches for creating uniform and reproducible cell-laden alginate microparticle structures.
- To highlight methods for developing well-regulated cellular structures within alginate microparticles.
- To discuss the potential of these engineered microparticles for drug screening and cell-based therapy.
Main Methods:
- Overview of capillary nozzle systems for microparticle generation.
- Discussion of microfluidic droplet systems for controlled encapsulation.
- Highlighting non-chip based high-throughput microfluidic systems for scalable production.
Main Results:
- Demonstration of various engineering approaches to generate diverse alginate microparticle structures.
- Emphasis on achieving uniform and reproducible cell distribution within microparticles.
- Identification of methods to regulate spatiotemporal cell distribution within the hydrogel matrix.
Conclusions:
- Engineered alginate microparticles offer a promising platform for drug screening and cell-based therapies.
- Current limitations in fabrication and clinical translation need to be addressed.
- Future directions focus on refining microparticle engineering for broader clinical applications.

